In 2024, the net loss of biotech company BioNTech SE was 665 million euros, compared to around 9.4 billion euros of net profit in 2022. This statistic illustrates the profit (after income taxes) of BioNTech SE from 2017 to 2024. On November 9th, 2020, German biotech company BioNTech in cooperation with U.S. pharma giant Pfizer were the first to announce a proven COVID-19 vaccine to be ready for mass production by year-end.
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how ÌÇÐÄÆƽâ°æ can support your business.
BioNTech, & U.S. Securities and Exchange Commission. (March 10, 2025). Net profit of BioNTech SE from 2017 to 2024 (in million euros) [Graph]. In ÌÇÐÄÆƽâ°æ. Retrieved July 16, 2026, from /statistics/1300589/profit-biontech-se/
BioNTech, und U.S. Securities and Exchange Commission. "Net profit of BioNTech SE from 2017 to 2024 (in million euros)." Chart. March 10, 2025. ÌÇÐÄÆƽâ°æ. Accessed July 16, 2026. /statistics/1300589/profit-biontech-se/
BioNTech, U.S. Securities and Exchange Commission. (2025). Net profit of BioNTech SE from 2017 to 2024 (in million euros). ÌÇÐÄÆƽâ°æ. ÌÇÐÄÆƽâ°æ Inc.. Accessed: July 16, 2026. /statistics/1300589/profit-biontech-se/
BioNTech, and U.S. Securities and Exchange Commission. "Net Profit of Biontech Se from 2017 to 2024 (in Million Euros)." ÌÇÐÄÆƽâ°æ, ÌÇÐÄÆƽâ°æ Inc., 10 Mar 2025, /statistics/1300589/profit-biontech-se/
BioNTech & U.S. Securities and Exchange Commission, Net profit of BioNTech SE from 2017 to 2024 (in million euros) ÌÇÐÄÆƽâ°æ, /statistics/1300589/profit-biontech-se/ (last visited July 16, 2026)
Net profit of BioNTech SE from 2017 to 2024 (in million euros) [Graph], BioNTech, & U.S. Securities and Exchange Commission, March 10, 2025. [Online]. Available: /statistics/1300589/profit-biontech-se/
